Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form... Structure Therapeutics Inc.’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results